EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dietary Leucine Restriction Suppresses Platelet‐Driven HCC Growth by Attenuating mTOR Signaling

Xeulian Ruan, Guiyong Ou, Cuiju Mo, Yi Zhang, Shanzi Qin, Yongling Chen, Dan Li, Liuying Nie, Li Xie, Zuojian Hu iD

Cancer Science · 28.10.2026

DOI: 10.1111/cas.70574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 28.10.2026. Verfasst von Xeulian Ruan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelets play a crucial role in regulating tumor progression, but the mechanisms underlying platelet‐induced metabolic reprogramming in hepatocellular carcinoma (HCC) remain incompletely understood. Here, metabolomic profiling identified significant accumulation of leucine in HCC cells following platelet incubation. Co‐culture with platelets promoted HCC cell proliferation, migration, and invasion in complete medium, whereas leucine deprivation in the co‐culture medium attenuated these malignant behaviors. Mechanistically, platelets selectively stimulated the phosphorylation of S6K1 and downstream S6, an activation that was suppressed under leucine‐deficient conditions. In addition, pharmacological inhibition of S6K1 activity using PF‐4708671 reduced platelet‐promoted cellular proliferation, migration, and invasion, confirming the S6K1/S6 axis as an essential functional effector of this response. In vivo, dietary leucine restriction reduced tumor growth following platelet pre‐incubation in the MHCC‐97H xenograft model. Together, these findings demonstrate that leucine accumulation and subsequent S6K1/S6 activation mediate platelet‐promoted HCC progression, indicating that targeting leucine availability or S6K1 signaling may offer therapeutic strategies for platelet‐associated HCC.

Schlagwörter

Stichwörter der Autor:innen

S6K1hepatocellular carcinomaleucine deprivationmetabolomicsplatelet

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Department of Blood Transfusion, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University; Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
  • Department of Blood Transfusion, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

ORCID-Profile: Zuojian Hu

Zitieren

APA

Ruan, X., Ou, G., Mo, C., Zhang, Y., Qin, S., Chen, Y., Li, D., Nie, L., Xie, L., & Hu, Z. (2026). Dietary Leucine Restriction Suppresses Platelet‐Driven HCC Growth by Attenuating mTOR Signaling. Cancer Science. https://doi.org/10.1111/cas.70574

Vancouver

Ruan X, Ou G, Mo C, Zhang Y, Qin S, Chen Y, et al. Dietary Leucine Restriction Suppresses Platelet‐Driven HCC Growth by Attenuating mTOR Signaling. Cancer Science. 2026. doi:10.1111/cas.70574

BibTeX
@article{Ruan2026,
  author = {Ruan, Xeulian and Ou, Guiyong and Mo, Cuiju and Zhang, Yi and Qin, Shanzi and Chen, Yongling and Li, Dan and Nie, Liuying and Xie, Li and Hu, Zuojian},
  title = {Dietary Leucine Restriction Suppresses Platelet‐Driven HCC Growth by Attenuating mTOR Signaling},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70574}
}
Kostenlos starten →